000 01335cam a2200361 a 4500
005 20250918124954.0
008 110214s2009 nyua b 001 0 eng
020 _a9781420073171 (hb : alk. paper)
_cRM812.96
020 _a1420073176 (hb : alk. paper)
039 9 _a201107141002
_bazhari
_c201103041215
_druzini
_y02-14-2011
_zrazalis
040 _aUKM
060 _aQV778
_b.P536 2009 9
090 _aQV778.P536 2009 9
245 0 0 _aPharmaceutical preformulation and formulation :
_ba practical guide from candidate drug selection to commercial dosage form /
_cedited by Mark Gibson
250 _a2nd ed.
260 _aNew York :
_bInforma Healthcare,
_cc2009
300 _ax, 541 p. :
_bill. ;
_c27 cm.
490 1 _aDrugs and the pharmaceutical sciences ;
_vv. 199
504 _aIncludes bibliographical references and index
650 2 _aDrug Compounding
650 2 _aBiopharmaceutics
_xmethods
650 2 _aDosage Forms
650 2 _aDrug Discovery
650 2 _aDrug evaluation
700 1 _aGibson, Mark,
_d1957-
830 0 _aDrugs and the pharmaceutical sciences ;
_vv. 199
907 _a.b14944248
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQV778.P536 2009 9
914 _avtls003456269
991 _aJabatan Farmasi, KKL
998 _ad
_b2011-01-02
_cm
_da
_feng
_gnyu
_y0
_z.b14944248
999 _c479287
_d479287